Safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of AZD2936, a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-experienced... von Rohrberg, Kristoffer Staal, Brandão, Mariana, Castanon Alvarez, Eduardo, Felip, Enriqueta, Gort, Eelke Hiddo, Hiltermann, T.Jeroen Jeroen Nicolaas, Izumi, Hiroki, Kim, Dong-Wan, Kim, Sang-We, Paz-Ares, Luis G., Solomon, Benjamin J., Steinbusch, Laurie, Wauters, Els, Yoshida, Tatsuya, Chen, Huifang, Goldwin, Andrew, Jiang, Yu, Achour, Ikbel, Drachsler, Moritz Wolfgang, Cho, Byoung Chul

Volltext